iMeds.se

Acnatac

Information för alternativet: Acnatac 10 Mg/G + 0,25 Mg/G Gel, visa andra alternativ
Document: Acnatac gel ENG PL change

Package leaflet: Information for the user


Acnatac 10 mg/g + 0.25 mg/g gel
clindamycin and tretinoin


Read all of this leaflet carefully before you start using this medicine because it contains important information for you.


What is in this leaflet:

1. What Acnatac is and what it is used for

2. What you need to know before you use Acnatac

3. How to use Acnatac

4. Possible side effects

How to store Acnatac

6. Contents of the pack and other information


1. What Acnatac is and what it is used for


Acnatac contains the active substances clindamycin and tretinoin.


Clindamycin is an antibiotic. It limits the growth of bacteria associated with acne and the inflammation caused by these bacteria.


Tretinoin normalizes the growth of superficial skin cells and causes normal shedding of the cells that clog the hair follicles in areas with acne. This prevents the build-up of sebum and the formation of early acne lesions (blackheads and whiteheads).


These active substances are more effective when combined than when used separately.


Acnatac is used on the skin to treat acne in patients 12 years and older.



2. What you need to know before you use Acnatac


DO NOT use Acnatac:

if you are allergic to clindamycin, tretinoin, or any of the other ingredients of this medicine (listed in section 6).


If any of the above applies to you, do not use this medicine and talk to your doctor.


Warnings and precautions

An effective sunscreen with Sun Protection Factor (SPF) of at least 30 and protective clothing (such as a hat) should be used any time you are outside.

If nevertheless your face becomes sunburnt, stop medication until your skin has healed.


Other medicines and Acnatac

Please tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines. This includes medicines that you buy without a prescription or herbal medicines. This is because Acnatac can affect the way some other medicines work. Also some other medicines can affect the way Acnatac works.


If you have used any preparations that contain sulphur, salicylic acid, benzoyl peroxide or rescinol or any chemical abrasives; you will need to wait until the effect of those have subsided until you start using this medicine. Your doctor will tell you when you can start using Acnatac.


Do not use medicated soaps cleansers or scrubbing solutions with strong drying effect during treatment with Acnatac. You should be careful when using the following that may have a drying effect: abrasive soaps, soaps and cosmetics and products with high concentrations of alcohol, astringents, spices or lime.


You should ask your doctor for advice before using this medicine together with other medicinal products containing erythromycin or metronidazole, aminoglycosides, other antibiotics or corticosteroids or if you are receiving neuromuscular blocking medicines e.g muscle relaxants used in anesthesia.


Warfarin or similar medicines – used to thin the blood. You may be more likely to have a bleed. Your doctor may need to take regular blood tests to check how well your blood can clot.


Pregnancy, breast-feeding and fertility

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.


You should not use this medicine if you are pregnant, especially during the first three months of the pregnancy, or if you are breastfeeding. It is not known if Acnatac may harm your unborn baby or pass through your milk and harm your baby.


If you are a woman of child-bearing age you should use contraception while using this medicine and for one month after discontinuation of treatment.


Driving and using machines

Acnatac is unlikely to have an effect on the ability to drive or operate machines.


Acnatac contains methylparahydroxybenzoate, propylparahydroxybenzoate and butyl hydroxytoluene.

Methylparahydroxybenzoate (E218) and propylparahydroxybenzoate (E216) may cause allergic reactions (possibly delayed).

Butyl hydroxytoluene (E321) may cause local skin reactions (e.g. contact dermatitis), or irritation to the eyes and mucous membranes.





3. How to use Acnatac



Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.


The recommended dose is:

A pea-sized amount of Acnatac should be applied once daily at bedtime.


Method of administration

Wash your face gently with mild soap and warm water and pat your skin dry with a towel. Squeeze a pea-sized amount of gel onto the fingertip. Dab the gel on your forehead, chin, nose and both cheeks, and then gently spread it evenly over your whole face.


Do not use more than the amount that has been suggested by your doctor, or apply the product more frequently than instructed. Too much medication may irritate the skin, and will not give faster or better results.


Duration of treatment

To get the best results with Acnatac, it is necessary to use it properly and not stop using it as soon as your acne starts to get better. Typically, it may take several weeks to have an optimal effect. In some cases, it may take up to 12 weeks. Please contact your doctor if symptoms persist for more than 12 weeks, as your doctor will need to reevaluate your treatment.


If you use more Acnatac than you should

You will not get faster or better results by using more Acnatac than recommended. If you use to much marked redness, peeling, or discomfort may occur. In such cases, the face should be gently washed with a mild soap and lukewarm water. The use of this medicine should be stopped until all these symptoms have gone away.


Overdose may also result in side effects from you stomach and intenstine; including stomach pain, nausea, vomiting and diarrhoea. In such cases, the use of this medicine should be discontinued and your doctor should be contacted.


Acnatac is only for use on the skin. In case of accidental ingestion, contact your doctor or go to the nearest hospital casualty department immediately.


If you forget to use Acnatac

If you forget to use Acnatac at bedtime, you should apply the next dose at the usual time. You should not double the dose to make up for the forgotten dose.

If you have any further questions on the use of this product, ask your doctor or pharmacist.




4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.


Uncommon: may affect up to 1 in 100 people

Acne, dry skin, redness of the skin, increased sebum production, photosensitivity reaction, itching, rash, scaly rash, scaling of the skin, sunburn

Application site reactions such as burning, inflamed skin, dryness, redness of the skin


Rare: may affect up to 1 in 1,000 people

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.


5. How to store Acnatac


Keep this medicine out of the sight and reach of children.


Do not store above 25C. Do not freeze.

Keep the tube tightly closed.


Do not use this medicine after the expiry date which is stated on the carton and tube after “EXP”. The expiry date refers to the last day of that month.


Shelf life after first opening: 3 months


Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.


6. Contents ofthe pack and other information

What Acnatac contains



What Acnatac looks like and contents of the pack


This medicinal product is a translucent yellow gel.


This medicinal product is available in aluminium tubes containing 30 g gel or 60 g gel.

Not all pack sizes may be marketed.



Marketing Authorisation Holder and Manufacturer


<[To be completed nationally]>


{Name and address}

<{tel}>

<{fax}>

<{e-mail}>


<This medicinal product is authorised in the Member States of the EEA under the following names:>


<{Name of the Member State}> <{Name of the medicinal product}>

<{Name of the Member State}> <{Name of the medicinal product}>


This leaflet was last revised in 16 December 2014.



5